Publications

5674 Results

Trisomy 15 is frequently observed as a minor clone in patients with anemia/MDS/NHL and as a major clone in patients with AML

Authors
JR Batanian;ML Slovak;A Mohamed;S Dobin;FW Luthardt;EA Keitges
Journal / Conference
Cancer Genetics and Cytogenetics 121:186-189
Year
2000
Research Committee(s)
Leukemia

Intergroup 0116 (SWOG 9008)- Phase III trial of postoperative adjuvant radiochemotherapy for high risk gastric and gastroesophageal (GE) junction adenocarcinoma (ACA): evaluation of efficacy and radiotherapy treatment planning

Authors
S Smalley;J Benedetti;L Gunderson;J Martenson;J Tepper;K Kiel;A Lichter;J Forman;J Macdonald
Journal / Conference
Int J Radiat Oncol Biol Phys 48(3)Suppl:111-112
Year
2000
Research Committee(s)
Gastrointestinal
Study Number(s)
SWOG-9008 (INT-0116) (RTOG-9018) (NCCTG-90-41-51) (ECOG-6290) (CALGB-9195)

Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group study.

Authors
ML Slovak;KJ Kopecky;PA Cassileth;DP Harrington;KS Theil;A Mohamed;E Paietta;CL Willman;DR Head;JM Rowe;SJ Forman;FR Appelbaum
Journal / Conference
Blood 96(13):4075-4083
Year
2000
Research Committee(s)
Leukemia
Study Number(s)
SWOG-9034 (EST-3489) (CALGB-9120)

Recombinant human eryghropoietin (EPO) as an adjunct to radiation therapy (RT) and cisplatin for stage IIB-IVA carcinoma of the cervix: a Southwest Oncology Group study

Authors
RS Lavey;PY Liu;BE Greer;PC Cheng;WR Robinson;BJ Monk;RB Wynn;ME Conrad;D Alberts
Journal / Conference
Radiotherapy & Oncology 56(Suppl.1):S92(#330)
Year
2000
Research Committee(s)
Gynecologic
Study Number(s)
SWOG-9318

Ten-year follow-up of SWOG 8269: a phase 2 trial of concomitant cisplatin-etoposide (PE) and daily thoracic radiotherapy (TRT) in limited small cell lung cancer (L-SCLC)

Authors
CR Thomas;DJ Giroux;LM Janaki;AT Turrisi;JJ Crowley;JD McCracken;RB Livingston;DR Gandara
Journal / Conference
Radiology 217Suppl:261(#251)
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-8269

Dietary supplement use in the prostate cancer prevention trial: implications for study findings

Authors
ML Neuhouser;AR Kristal;RE Patterson;IM Thompson
Journal / Conference
American Society of Prevention Oncology :#76
Year
2000
Research Committee(s)
Cancer Control
Study Number(s)
SWOG-9217

High-and low-dose interferon alfa-2b in high-risk melanoma: first analysis of Intergroup trial E1690/S9111/C9190

Authors
JM Kirkwood;J Ibrahim;VK Sondak;J Richards;LE Flaherty;MS Ernstoff;TJ Smith;U Rao;M Steele;RH Blum
Journal / Conference
Journal of Clinical Oncology 18(12):2444-2458
Year
2000
Research Committee(s)
Melanoma
Study Number(s)
SWOG-9111 (EST-1690)

Phase II evaluation of paclitaxel by 96-hour infusion in stage IIIb and IV bronchioloalveolar carcinoma (BAC)

Authors
RB Vance;JJ Crowley;D Gandara
Journal / Conference
Lung Cancer 29(Suppl.2):7(#16)
Year
2000
Research Committee(s)
Lung
Study Number(s)
S9714

Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group

Authors
W Sause;P Kolesar;S Taylor;D Johnson;R Livingston;R Komaki;B Emami;W Curran, Jr;R Byhardt;A Rashid Dar;A Turrisi, III
Journal / Conference
Chest 117:358-364
Year
2000
Research Committee(s)
Lung
Study Number(s)
SWOG-8992 (RTOG-88-08) (ECOG-45-88)

Conventiional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer

Authors
EA Stadtmauer;A O'Neill;LJ Goldstein;PA Crilley;KF Mangan;JN Ingle;I Brodsky;S Martino;HM Lazarus;JK Erban;C Sickles;JH Glick
Journal / Conference
New England Journal of Medicine 342(15):1069-1076
Year
2000
Research Committee(s)
Breast
Study Number(s)
SWOG-9412